Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

innoVitro GmbH

Start a request
Advantage
Year Established:
2017
Website:
innovitro.de
Headquarters:
Jülich, NRW, DE
Company Type:
Small Business (1-10M TTM Revenue)
Completed Requests:
2
Open Requests:
3

innoVitro GmbH is a Contract Research Organisation operating from Jülich, Germany providing human-based cardiac risk and efficacy screening services for Pharma, Biotech and Academia worldwide. Each service is custom-tailored by an expert team in close cooperation with the client and carried out as end-to-end study report in less than 6 weeks.

Screening parameters encompass structural and functional endpoints of human iPSC-derived cardiomyocytes, analysed with a high throughput 96-well hybrid system. Drug-induced changes of healthy or diseased cells can be assessed regarding cellular and electrophysiological properties (CardioExcyte Module) as well as changes in contractility (FLEXcyte 96 Module). Here, adult-like contractile force analysis is provided through flexible membranes mimicking in vivo conditions of the human heart.

Media


Site Badges
innoVitro GmbH
2 Artilleriestraße Jülich, NRW, 52428 Germany

Get started

If your organization has a Scientist.com marketplace, you can log in here to order products and services directly.

If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here.

To order products instantly, request access below.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service